Search Results

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice.

• Authors : Xue, Xiaoyong¹ (AUTHOR); Wang, Le¹ (AUTHOR); Wu, Ruiyu² (AUTHOR)

Subjects: *LIPID analysis; *CHINESE medicine; *METABOLIC disorders

• Source: Chinese Medicine. 6/6/2024, Vol. 19, p1-22. 22p.

Record details

Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization.

• Authors : Gao, Xinxin¹ (AUTHOR); Zhu, Zhigang² (AUTHOR); Bao, Yiyang¹ (AUTHOR)

Subjects: *THERAPEUTIC use of probiotics; *PHYTOTHERAPY; *GLUCOSE metabolism

• Source: Chinese Medicine. 6/3/2024, Vol. 19 Issue 1, p1-16. 16p.

Record details

Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice.

• Authors : Lontro Alves, Luciana¹ (AUTHOR); Gomes Pereira, Priscila¹ (AUTHOR); Torres Ciambarella, Bianca¹ (AUTHOR)

Subjects: *PHYTOTHERAPY; *NON-alcoholic fatty liver disease; *ADIPOSE tissues

• Source: Journal of Obesity. 5/27/2024, Vol. 2024, p1-14. 14p.

Record details

Strength Training Protects High-Fat-Fed Ovariectomized Mice against Insulin Resistance and Hepatic Steatosis.

• Authors : Santos, Jessica D. M.¹ (AUTHOR); Silva, José F. T.¹ (AUTHOR); Alves, Ester dos S.¹ (AUTHOR)

Subjects: *MICE; *INSULIN resistance; *FATTY liver

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5066. 17p.

Record details

NLRP3基因敲减对高脂高糖饮食诱导的非酒精性脂肪性肝炎 小鼠模型的影响.

• Authors : 黄 倩^1,2,3,4; 王卓媛^1,2,3,4; 安梓铭^1,2,3,4

• Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. May2024, Vol. 40 Issue 5, p952-960. 9p.

Record details

Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice.

• Authors : Das, Manasi^1,2 (AUTHOR) ; Kumar, Deepak^1,2 (AUTHOR); Sauceda, Consuelo^1,2 (AUTHOR)

Subjects: *INFLAMMATION prevention; *REDUCING diets; *METABOLIC disorders

• Source: Cancers. Apr2024, Vol. 16 Issue 8, p1513. 17p.

Record details

Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture.

• Authors : Guo, Yihui¹ (AUTHOR); Zhang, Liying² (AUTHOR); Li, Mengyuan³ (AUTHOR)

Subjects: *LIPID metabolism; *NON-alcoholic fatty liver disease; *RESEARCH funding

• Source: International Journal of Endocrinology. 4/10/2024, Vol. 2024, p1-13. 13p.

Record details

Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse.

• Authors : Smagris, Eriks¹ (AUTHOR); Shihanian, Lisa M.¹ (AUTHOR); Mintah, Ivory J.¹ (AUTHOR)

Subjects: *MICE; *KNOCKOUT mice; *HEPATIC fibrosis

• Source: PLoS Genetics. 3/4/2024, Vol. 20 Issue 3, p1-28. 28p.

Record details

Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice.

• Authors : Wyss, Jacqueline¹ (AUTHOR); Raselli, Tina² (AUTHOR); Wyss, Annika² (AUTHOR)

Subjects: *GUT microbiome; *NON-alcoholic fatty liver disease; *HEPATIC fibrosis

• Source: BMC Microbiology. 2/28/2024, Vol. 24 Issue 1, p1-15. 15p.

Record details

Graphislactone A, a Fungal Antioxidant Metabolite, Reduces Lipogenesis and Protects against Diet-Induced Hepatic Steatosis in Mice.

• Authors : Lee, Yeonmi¹ (AUTHOR); Jang, Hye-Rim¹ (AUTHOR); Lee, Dongjin¹ (AUTHOR)

Subjects: *FATTY liver; *NON-alcoholic fatty liver disease; *LIPID synthesis

• Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 2, p1096. 16p.

Record details